Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,925 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin.
Ueda Y, Miyake T, Egawa-Takata T, Miyatake T, Matsuzaki S, Yokoyama T, Yoshino K, Fujita M, Enomoto T, Kimura T. Ueda Y, et al. Among authors: yokoyama t. Cancer Chemother Pharmacol. 2011 Apr;67(4):829-35. doi: 10.1007/s00280-010-1384-z. Epub 2010 Jun 20. Cancer Chemother Pharmacol. 2011. PMID: 20563809 Free PMC article.
Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later.
Miyake T, Ueda Y, Egawa-Takata T, Matsuzaki S, Yokoyama T, Miyoshi Y, Kimura T, Yoshino K, Fujita M, Yamasaki M, Enomoto T, Kimura T. Miyake T, et al. Among authors: yokoyama t. Am J Obstet Gynecol. 2011 Jun;204(6):535.e1-5. doi: 10.1016/j.ajog.2011.02.034. Epub 2011 Apr 8. Am J Obstet Gynecol. 2011. PMID: 21481836
Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization.
Miyoshi Y, Miyatake T, Ueda Y, Morimoto A, Yokoyama T, Matsuzaki S, Kimura T, Yoshino K, Fujita M, Ohashi H, Morii E, Enomoto T, Kimura T. Miyoshi Y, et al. Among authors: yokoyama t. Arch Gynecol Obstet. 2012 May;285(5):1427-32. doi: 10.1007/s00404-011-2147-8. Epub 2011 Nov 23. Arch Gynecol Obstet. 2012. PMID: 22109382
Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
Kobayashi E, Ueda Y, Matsuzaki S, Yokoyama T, Kimura T, Yoshino K, Fujita M, Kimura T, Enomoto T. Kobayashi E, et al. Among authors: yokoyama t. Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1902-12. doi: 10.1158/1055-9965.EPI-12-0646. Epub 2012 Sep 7. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22962405 Review.
Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
Matsuzaki S, Enomoto T, Serada S, Yoshino K, Nagamori S, Morimoto A, Yokoyama T, Kim A, Kimura T, Ueda Y, Fujita M, Fujimoto M, Kanai Y, Kimura T, Naka T. Matsuzaki S, et al. Among authors: yokoyama t. Int J Cancer. 2014 Apr 15;134(8):1796-809. doi: 10.1002/ijc.28526. Epub 2013 Oct 21. Int J Cancer. 2014. PMID: 24150977
Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman LD, Sood AK. Matsuo K, et al. Among authors: yokoyama t. Gynecol Oncol. 2015 Feb;136(2):198-204. doi: 10.1016/j.ygyno.2014.12.006. Epub 2014 Dec 10. Gynecol Oncol. 2015. PMID: 25497604
3,925 results